 PDS Biotechnology Corporation NASDAQ:PDSB Q2 2022 Results Earnings Conference Call August 8, 2022 8:00 AM ET Company Participants Gabrielle DeGravina - Investor Relations, CG Capital Frank Bedu-Addo - Chief Executive Officer Lauren Wood - Chief Medical Officer Matthew Hill - Chief Financial Officer Conference Call Participants Louise Chen - Cantor Fitzgerald James Molloy - Alliance Global Partners Leland Gershell - Oppenheimer Co. Joseph Pantginis - H. C. Wainwright Co. Robert LeBoyer - Noble Capital Markets Operator Greetings. 